Next Article in Journal
Chemical Composition and Evaluation of the Biological Properties of the Essential Oil of the Dietary Phytochemical Lippia citriodora
Next Article in Special Issue
NMR-Fragment Based Virtual Screening: A Brief Overview
Previous Article in Journal
Fermentation-Guided Natural Products Isolation of a Grape Berry Triacylglyceride that Enhances Ethyl Ester Production
Previous Article in Special Issue
Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion
Review

Current NMR Techniques for Structure-Based Drug Discovery

1
Institute for Protein Research, Osaka University, Osaka 565-0871, Japan
2
Graduate School of Engineering, Yokohama National University, Yokohama 240-8501, Japan
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(1), 148; https://doi.org/10.3390/molecules23010148
Received: 27 October 2017 / Revised: 28 December 2017 / Accepted: 9 January 2018 / Published: 12 January 2018
(This article belongs to the Special Issue Recent Advances in Biomolecular NMR Spectroscopy)
A variety of nuclear magnetic resonance (NMR) applications have been developed for structure-based drug discovery (SBDD). NMR provides many advantages over other methods, such as the ability to directly observe chemical compounds and target biomolecules, and to be used for ligand-based and protein-based approaches. NMR can also provide important information about the interactions in a protein-ligand complex, such as structure, dynamics, and affinity, even when the interaction is too weak to be detected by ELISA or fluorescence resonance energy transfer (FRET)-based high-throughput screening (HTS) or to be crystalized. In this study, we reviewed current NMR techniques. We focused on recent progress in NMR measurement and sample preparation techniques that have expanded the potential of NMR-based SBDD, such as fluorine NMR (19F-NMR) screening, structure modeling of weak complexes, and site-specific isotope labeling of challenging targets. View Full-Text
Keywords: nuclear magnetic resonance (NMR); NMR-based fragment screening; NMR-based lead optimization; ligand-based NMR; protein-based NMR; fluorine-19 (19F) NMR; site-specific isotope labeling; protein-protein interaction (PPI) breaker/stabilizer nuclear magnetic resonance (NMR); NMR-based fragment screening; NMR-based lead optimization; ligand-based NMR; protein-based NMR; fluorine-19 (19F) NMR; site-specific isotope labeling; protein-protein interaction (PPI) breaker/stabilizer
Show Figures

Figure 1

MDPI and ACS Style

Sugiki, T.; Furuita, K.; Fujiwara, T.; Kojima, C. Current NMR Techniques for Structure-Based Drug Discovery. Molecules 2018, 23, 148. https://doi.org/10.3390/molecules23010148

AMA Style

Sugiki T, Furuita K, Fujiwara T, Kojima C. Current NMR Techniques for Structure-Based Drug Discovery. Molecules. 2018; 23(1):148. https://doi.org/10.3390/molecules23010148

Chicago/Turabian Style

Sugiki, Toshihiko, Kyoko Furuita, Toshimichi Fujiwara, and Chojiro Kojima. 2018. "Current NMR Techniques for Structure-Based Drug Discovery" Molecules 23, no. 1: 148. https://doi.org/10.3390/molecules23010148

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop